Effect of Renal Insufficiency on Cardiovascular Outcomes
肾功能不全对心血管结局的影响
基本信息
- 批准号:6601135
- 负责人:
- 金额:$ 2.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-06-15 至 2004-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Verbatim from the application): Cardiovascular disease accounts
for almost half of the reported deaths for patients receiving maintenance
dialysis. Because incident dialysis patients often have advanced coronary
artery disease that is less amenable to treatment as compared with patients
with normal renal function, the greatest impact of therapy will be obtained
through invention among patients with renal insufficiency, prior to their
development of ESRD and earlier in the development of the coronary artery
lesions. This proposal will define the impact of varying degrees of chronic
renal insufficiency on five-year survival among patients with significant
coronary artery disease. This study will further compare patient survival
following treatment for coronary artery disease (medical, percutaneous coronary
artery intervention and coronary artery bypass grafting) among patients with
mild, moderate, and severe renal insufficiency. After evaluating these clinical
outcomes, this proposal will estimate the cumulative five-year medical resource
utilization (rehospitalizations and cardiac procedures) and costs for patients
with chronic renal insufficiency and significant coronary artery disease to
compare costs among major patient subgroups. A retrospective cohort design will
be used to take advantage of the Duke Databank for Cardiovascular Diseases
(DDCD), a large, comprehensive patient database, maintained by the Duke
Clinical Research Institute (DCRI) and its associated hospital and physician
administrative databases. This study will examine the cardiovascular outcomes
that affect the survival of patients with chronic renal insufficiency and
patients receiving chronic dialysis. The results of this study will provide
evidence for early intervention among the pre-ESRD population with chronic
renal insufficiency to improve maximize the efficacy of coronary
revascularization and improve survival.
描述(来自申请的逐字记录):心血管疾病账户
在接受维持治疗的患者中,
透析因为透析患者通常有晚期冠状动脉
与患者相比,
在肾功能正常的情况下,治疗将产生最大的影响
肾功能不全患者中,在他们
终末期肾病的发展和冠状动脉的早期发展
病变该提案将界定不同程度的慢性
肾功能不全对五年生存率的影响
冠心病这项研究将进一步比较患者生存率
冠状动脉疾病治疗后(药物、经皮冠状动脉
冠状动脉旁路移植术(CABG)
轻度、中度和重度肾功能不全。在评估这些临床
结果,本提案将估计五年累积医疗资源
患者的利用率(再住院和心脏手术)和成本
慢性肾功能不全和严重的冠状动脉疾病,
比较主要患者亚组的成本。回顾性队列设计将
用于利用杜克心血管疾病数据库
(DDCD),由杜克维护的大型综合患者数据库
临床研究所(DCRI)及其相关医院和医生
行政数据库。本研究将检查心血管结局
影响慢性肾功能不全患者的生存,
接受慢性透析的患者。这项研究的结果将提供
早期干预ESRD前人群的证据
最大限度地改善肾功能不全的冠心病疗效
血运重建和提高生存率。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.
- DOI:10.1007/s10916-008-9190-4
- 发表时间:2009-08
- 期刊:
- 影响因子:5.3
- 作者:Eisenstein, Eric L.;Sun, Jie L.;Anstrom, Kevin J.;DeLong, Elizabeth R.;Szczech, Lynda A.;Mark, Daniel B.
- 通讯作者:Mark, Daniel B.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEVE J SCHWAB其他文献
STEVE J SCHWAB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEVE J SCHWAB', 18)}}的其他基金
Effect of Renal Insufficiency on Cardiovascular Outcomes
肾功能不全对心血管结局的影响
- 批准号:
6326540 - 财政年份:2001
- 资助金额:
$ 2.9万 - 项目类别:
HEMODIALYSIS VASCULAR ACCESS CLINICAL TRIALS CONSORTIUM
血液透析血管通路临床试验联盟
- 批准号:
6381968 - 财政年份:2000
- 资助金额:
$ 2.9万 - 项目类别:
HEMODIALYSIS VASCULAR ACCESS CLINICAL TRIALS CONSORTIUM
血液透析血管通路临床试验联盟
- 批准号:
6291558 - 财政年份:2000
- 资助金额:
$ 2.9万 - 项目类别:
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTS
血液透析患者的发病率和死亡率
- 批准号:
2518436 - 财政年份:1994
- 资助金额:
$ 2.9万 - 项目类别:
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTS
血液透析患者的发病率和死亡率
- 批准号:
2149911 - 财政年份:1994
- 资助金额:
$ 2.9万 - 项目类别:
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTS
血液透析患者的发病率和死亡率
- 批准号:
2149910 - 财政年份:1994
- 资助金额:
$ 2.9万 - 项目类别:
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTS
血液透析患者的发病率和死亡率
- 批准号:
2905710 - 财政年份:1994
- 资助金额:
$ 2.9万 - 项目类别:
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTS
血液透析患者的发病率和死亡率
- 批准号:
2770492 - 财政年份:1994
- 资助金额:
$ 2.9万 - 项目类别:
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTS
血液透析患者的发病率和死亡率
- 批准号:
6177118 - 财政年份:1994
- 资助金额:
$ 2.9万 - 项目类别:
MORBIDITY AND MORTALITY IN HEMODIALYSIS PATIENTS
血液透析患者的发病率和死亡率
- 批准号:
2149909 - 财政年份:1994
- 资助金额:
$ 2.9万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 2.9万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 2.9万 - 项目类别: